187 related articles for article (PubMed ID: 21149963)
1. Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy.
Thamake SI; Raut SL; Ranjan AP; Gryczynski Z; Vishwanatha JK
Nanotechnology; 2011 Jan; 22(3):035101. PubMed ID: 21149963
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells.
Yallapu MM; Gupta BK; Jaggi M; Chauhan SC
J Colloid Interface Sci; 2010 Nov; 351(1):19-29. PubMed ID: 20627257
[TBL] [Abstract][Full Text] [Related]
3. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
Sun B; Ranganathan B; Feng SS
Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
6. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
7. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
8. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
[TBL] [Abstract][Full Text] [Related]
9. Folate targeted polymeric 'green' nanotherapy for cancer.
Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
[TBL] [Abstract][Full Text] [Related]
11. Intracellular drug release from curcumin-loaded PLGA nanoparticles induces G2/M block in breast cancer cells.
Verderio P; Bonetti P; Colombo M; Pandolfi L; Prosperi D
Biomacromolecules; 2013 Mar; 14(3):672-82. PubMed ID: 23350530
[TBL] [Abstract][Full Text] [Related]
12. Glucosylated polymeric nanoparticles: a sweetened approach against blood compatibility paradox.
Thasneem YM; Sajeesh S; Sharma CP
Colloids Surf B Biointerfaces; 2013 Aug; 108():337-44. PubMed ID: 23563302
[TBL] [Abstract][Full Text] [Related]
13. Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
Thamake SI; Raut SL; Gryczynski Z; Ranjan AP; Vishwanatha JK
Biomaterials; 2012 Oct; 33(29):7164-73. PubMed ID: 22795543
[TBL] [Abstract][Full Text] [Related]
14. Effect of thiol functionalization on the hemo-compatibility of PLGA nanoparticles.
Thasneem YM; Sajeesh S; Sharma CP
J Biomed Mater Res A; 2011 Dec; 99(4):607-17. PubMed ID: 21953904
[TBL] [Abstract][Full Text] [Related]
15. PLGA/polymeric liposome for targeted drug and gene co-delivery.
Wang H; Zhao P; Su W; Wang S; Liao Z; Niu R; Chang J
Biomaterials; 2010 Nov; 31(33):8741-8. PubMed ID: 20727587
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872
[TBL] [Abstract][Full Text] [Related]
17. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
[TBL] [Abstract][Full Text] [Related]
18. Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles.
Fay F; Quinn DJ; Gilmore BF; McCarron PA; Scott CJ
Biomaterials; 2010 May; 31(14):4214-22. PubMed ID: 20185174
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8.
Bicho A; Peça IN; Roque AC; Cardoso MM
Int J Pharm; 2010 Oct; 399(1-2):80-6. PubMed ID: 20696228
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yin Y; Chen D; Qiao M; Lu Z; Hu H
J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
